eGFR imbalance and DOAC-VKA comparisons in kidney transplant recipients. Author's reply

Michele Rossi; Gregory Y H Lip

doi:10.1016/j.ejim.2026.106866

eGFR imbalance and DOAC-VKA comparisons in kidney transplant recipients. Author's reply

Eur J Intern Med. 2026 Jun:148:106866. doi: 10.1016/j.ejim.2026.106866. Epub 2026 Apr 14.

Authors

Michele Rossi¹, Gregory Y H Lip²

Affiliations

¹ Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Department of Life, Health & Environmental Sciences, University of L'Aquila, L'Aquila, Italy; Internal Medicine and Nephrology Division, ASL1 Avezzano-Sulmona-L'Aquila, San Salvatore Hospital, L'Aquila, Italy.
² Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom; Danish Center for Health Services, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark; Department of Cardiology, Lipidology and Internal Medicine with Intensive Coronary Care Unit, Medical University of Bialystok, Bialystok, Poland. Electronic address: gregory.lip@liverpool.ac.uk.

PMID: 41986202
DOI: 10.1016/j.ejim.2026.106866

No abstract available

Keywords: Atrial Fibrillation; Chronic Kidney Disease; Direct Oral Anticoagulants; Kidney Transplant Recipients; Propensity Score Matching; Vitamin K Antagonists.

Publication types

Letter